Possible efficacy of lamivudine treatment to prevent hepatitis B virus reactivation due to rituximab therapy in a patient with non-Hodgkin's lymphoma

By Tsutsumi Y.  

Annals of Hematology, Vol. 83, Iss. 1, 2004-01 ,pp. : 58-60

Springer Publishing Company

Access to resources Recommend Favorite

Delayed hepatitis B virus reactivation after cessation of preemptive lamivudine in lymphoma patients treated with rituximab plus CHOP

By Dai Ming-Shen   Chao Tsu-Yi   Kao Woei-Yau   Shyu Rong-Yaun   Liu Tan-Mei  

Annals of Hematology, Vol. 83, Iss. 12, 2004-12 ,pp. : 769-774

Springer Publishing Company

Access to resources Recommend Favorite

Reactivation of hepatitis B virus during rituximab treatment of a patient with follicular lymphoma

By Yang Shih-Hung  

Annals of Hematology, Vol. 87, Iss. 4, 2008-04 ,pp. : 325-327

Springer Publishing Company

Access to resources Recommend Favorite

Preemptive use of interferon or lamivudine for hepatitis B reactivation in patients with aggressive lymphoma receiving chemotherapy

By Leaw Shiang   Yen Chia   Huang Wen   Chen Tsai   Su Wu   Tsao Chao  

Annals of Hematology, Vol. 83, Iss. 5, 2004-05 ,pp. : 270-275

Springer Publishing Company

Access to resources Recommend Favorite

Managing hepatitis B reactivation in renal transplant recipients: a 12-year review with emphasis on early detection and early use of lamivudine

By Tsai M.-K.   Lai M.-Y.   Hu R.-H.   Lee C.-J.   Lee P.-H.  

Transplantation Proceedings, Vol. 32, Iss. 7, 2000-11 ,pp. : 1935-1936

Elsevier

Access to resources Recommend Favorite